Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR-Mutated Advanced NSCLC

Journal:

The New England Journal of Medicine

Published:

2025-10-20

DOI:

10.1056/nejmoa2512071

Affiliations:

36

Authors:

34

Go to article

Institutions	Authors	Share
Sichuan Kelun Pharmaceutical Co., Ltd., China	4.000000	0.12
State Key Laboratory of Oncology in South China, SYSUCC, China	3.000000	0.09
Hunan Cancer Hospital, China	1.500000	0.04
Central South University (CSU), China	1.500000	0.04
The First Affiliated Hospital of Xi'an Jiaotong University, XJTU, China	1.000000	0.03
University of Electronic Science and Technology of China (UESTC), China	1.000000	0.03
Shandong Cancer Hospital, China	1.000000	0.03
Tianjin Medical University Cancer Institute and Hospital, TMU, China	1.000000	0.03
Second Xiangya Hospital, CSU, China	1.000000	0.03
Liaoning Cancer Hospital and Institute, China	1.000000	0.03
Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine, China	1.000000	0.03
The First Affiliated Hospital of Nanchang University, China	1.000000	0.03
Shanghai Chest Hospital, SJTU, China	1.000000	0.03
Hubei Cancer Hospital (HBCH), China	1.000000	0.03
The First Hospital of Jilin University, China	1.000000	0.03
Zhongshan Hospital Minghang Meilong Branch, Fudan University, China	1.000000	0.03
Cancer Hospital of Yunnan Province, China	1.000000	0.03
Jiangxi Provincial Cancer Hospital, China	1.000000	0.03
First Affiliated Hospital, ZZU, China	1.000000	0.03
The Second Affiliated Hospital of Zunyi Medical University, China	1.000000	0.03
People's Hospital of Guangxi Zhuang Autonomous Region, China	1.000000	0.03
Harbin Medical University Cancer Hospital, China	1.000000	0.03
Shengjing Hospital of China Medical University, China	1.000000	0.03
Beijing Cancer Hospital / School of Oncology, PKUHSC, China	1.000000	0.03
Fujian Cancer Hospital, China	1.000000	0.03
Tumor Hospital of Guangxi Medical University, China	1.000000	0.03
Mianyang Central Hospital, China	0.500000	0.01
Sichuan Cancer Hospital, China	0.500000	0.01
Henan Cancer Hospital, ZZU, China	0.500000	0.01
Henan Academy of Innovations in Medical Science, China	0.500000	0.01

Interested in Oncology and Carcinogenesis?